April 12, 2013 / 6:46 AM / in 5 years

BTG says FDA accepts Varisolve for review

LONDON, April 12 (Reuters) - Speciality pharmaceutical company BTG said on Friday its Varisolve treatment for varicose veins has been accepted for review by the U.S. Food & Drug Administration (FDA) and could be approved and launched during the first half of 2014.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below